Inimex Pharmaceuticals

Innate Defense Regulators

Inimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body’s innate defenses without causing...

Total money raised: $26.5M

V5A 4T8 8540 Baxter Place

Burnaby, B.C.
Burnaby, B.C.

Phone: (604) 225-2251

Updated on Aug 24, 2009
Inimex Pharmaceuticals at CrunchBase
John R. North President & CEO
Martin (Marty) McConnell CFO
Oreola Donini Senior Director
Stephanie O'Brien Board Member
Pat Brady Director

June, 2008

Inimex Pharmaceuticals raised $22M in a Series B round from Canadian Medical Discoveries Fund, Astellas Venture Management, Morningside Group, Roche Venture Fund, BC Advantage Funds, Discovery Capital, BDC Venture Capital, and GrowthWorks Capital

July, 2004

Inimex Pharmaceuticals raised $4.5M in a Series A round from BDC Venture Capital, Canadian Medical Discoveries Fund, and GrowthWorks Capital

Inimex Pharmaceuticals Announces $2 Million Second Closing of Series A